Viewing Study NCT06241105


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-03-03 @ 1:09 AM
Study NCT ID: NCT06241105
Status: RECRUITING
Last Update Posted: 2024-02-05
First Post: 2024-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module